Trial Type: Other Hematopoietic

BH-P-GLORA-4
A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).
Protocol Status: OPEN TO ACCRUAL
Contact: Reagan, John
ALTE2131
Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer
Protocol Status: OPEN TO ACCRUAL
Trial Type: Basket Trials
Contact: DeNardo, Bradley
BH-P-LUMINA-3
A Multicenter, Open-label, Phase IIb Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (LUMINA 2)
Protocol Status: OPEN TO ACCRUAL
Contact: Hsu, Andrew